Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for the Management of CVD in CKD
NCT03636152Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2018
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in cardiovascular disease (CVD), atherosclerosis, sponsored by VA Office of Research & Development. Started Dec 2018; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
cardiovascular disease (CVD)atherosclerosis
Beyond the preview
Go deeper on NCT03636152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03636152.